<DOC>
	<DOCNO>NCT03000231</DOCNO>
	<brief_summary>The purpose study compare cardio-metabolic risk , glucose tolerance , night time blood pressure healthy control subject patient adrenal insufficiency . No intervention administer study observational .</brief_summary>
	<brief_title>Circadian Function Cardio-metabolic Risk Adrenal Insufficiency</brief_title>
	<detailed_description>We propose use case control design test main hypothesis compare healthy control subject match sex , age , adiposity race/ethnicity , patient adrenal insufficiency , whether primary secondary , disturbance circadian system associate high day day variability sleep time well elevated marker cardio-metabolic risk , include abnormal oral glucose tolerance reduce nocturnal blood pressure dip . A secondary hypothesis study adrenal insufficiency patient replacement regimen ( part standard care ongoing treatment ) result daytime cortisol profile approximate normal diurnal variation well cardio-metabolic function adrenal insufficiency patient grossly abnormal cortisol profile .</detailed_description>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Primary secondary adrenal insufficiency , Healthy match control , acute unstable health condition age 18 old Diabetes , Tertiary adrenal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>